Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
Redox Biol. 2018 Apr;14:354-360. doi: 10.1016/j.redox.2017.10.007. Epub 2017 Oct 11.
Products of ultraviolet (UV) irradiation such as reactive oxygen species (ROS) and nitric oxide (NO) stimulate melanin synthesis. Reactive sulfur species (RSS) have been shown to have strong ROS and NO scavenging effects. However, the instability and low retention of RSS limit their use as inhibitors of melanin synthesis. The free thiol at Cys34 on human serum albumin (HSA) is highly stable, has a long retention and possess a high reactivity for RSS. We report herein on the development of an HSA based RSS delivery system. Sulfane sulfur derivatives released from sodium polysulfides (NaS) react readily with HSA. An assay for estimating the elimination of sulfide from polysulfide showed that almost all of the sulfur released from NaS bound to HSA. The NaS-treated HSA was found to efficiently scavenge ROS and NO produced from chemical reagents. The NaS-treated HSA was also found to inhibit melanin synthesis in B16 melanoma cells and this inhibition was independent of the number of added sulfur atoms. In B16 melanoma cells, the NaS-treated HSA also inhibited the levels of ROS and NO induced by UV radiation. Finally, the NaS-treated HSA inhibited melanin synthesis from L-DOPA and mushroom tyrosinase and suppressed the extent of aggregation of melanin pigments. These data suggest that NaS-treated HSA inhibits tyrosinase activity for melanin synthesis via two pathways; by directly inhibiting ROS signaling and by scavenging NO. These findings indicate that NaS-treated HSA has potential to be an attractive and effective candidate for use as a skin whitening agent.
紫外线 (UV) 照射的产物,如活性氧 (ROS) 和一氧化氮 (NO),可刺激黑色素合成。已证明活性硫物种 (RSS) 具有很强的 ROS 和 NO 清除作用。然而,RSS 的不稳定性和低保留性限制了它们作为黑色素合成抑制剂的应用。人血清白蛋白 (HSA) 上半胱氨酸 (Cys34) 的游离巯基高度稳定,保留时间长,对 RSS 具有高反应性。我们在此报告了一种基于 HSA 的 RSS 输送系统的开发。多硫化物 (NaS) 释放的硫烷硫衍生物可与 HSA 迅速反应。一种用于估计从多硫化物中消除硫化物的测定表明,从 NaS 释放的几乎所有硫都与 HSA 结合。发现 NaS 处理的 HSA 可以有效地清除由化学试剂产生的 ROS 和 NO。还发现 NaS 处理的 HSA 抑制 B16 黑色素瘤细胞中的黑色素合成,并且这种抑制与添加的硫原子数无关。在 B16 黑色素瘤细胞中,NaS 处理的 HSA 还抑制了 UV 辐射诱导的 ROS 和 NO 水平。最后,NaS 处理的 HSA 抑制了 L-DOPA 和蘑菇酪氨酸酶诱导的黑色素合成,并抑制了黑色素色素的聚集程度。这些数据表明,NaS 处理的 HSA 通过两种途径抑制黑色素合成的酪氨酸酶活性;通过直接抑制 ROS 信号转导和清除 NO。这些发现表明,NaS 处理的 HSA 具有作为皮肤增白剂的有吸引力和有效的候选物的潜力。